|
HS Code |
374411 |
| Name | Beta-D-Ribofuranose 1,2,3,5-Tetraacetate |
| Chemical Formula | C14H18O9 |
| Molecular Weight | 330.29 g/mol |
| Cas Number | 13035-61-5 |
| Appearance | White to off-white solid |
| Melting Point | 83-85°C |
| Solubility | Soluble in chloroform, methanol, and ethanol |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C |
| Synonyms | Ribose tetraacetate, Tetra-O-acetyl-β-D-ribofuranose |
| Smiles | CC(=O)O[C@@H]1O[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1O |
As an accredited Beta-D-Ribofuranose 1,2,3,5-Tetraacetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tightly sealed 100g HDPE bottle with tamper-evident cap, labeled "Beta-D-Ribofuranose 1,2,3,5-Tetraacetate, 100g, for research use only." |
| Shipping | Beta-D-Ribofuranose 1,2,3,5-Tetraacetate is typically shipped in sealed, chemical-resistant containers, protected from moisture and extreme temperatures. It is handled as a non-hazardous substance but should be transported according to standard laboratory shipping protocols, ensuring proper labeling and documentation according to regulatory requirements. Expedited shipping may be used for temperature-sensitive orders. |
| Storage | **Beta-D-Ribofuranose 1,2,3,5-Tetraacetate** should be stored in a tightly closed container, protected from moisture and light. It should be kept in a cool, dry place, ideally at room temperature or lower (2–8°C). Ensure the storage area is well-ventilated and chemicals are clearly labeled. Avoid exposure to strong oxidizing agents and incompatible materials. |
Applications of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate in Industrial ManufacturingAs the direct producer of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate, we supply this essential intermediate mainly to established downstream industries requiring high-purity ribose derivatives for advanced chemical synthesis. Our raw material is formulated and quality-controlled to meet the demanding process integration and documentation requirements of specialty APIs, nucleoside analogs, and selective carbohydrate-based manufacturing. Below we outline several real-world industrial application sectors, each with their specific compliance frameworks, usage guidelines, integration stages, and distinct end products. 1. Nucleoside Pharmaceuticals SynthesisPharmaceutical manufacturers incorporate this tetraacetate primarily during the synthesis of modified nucleosides and nucleotide analog APIs for antiviral and anticancer medications. The acetyl-protected ribose backbone enables precise glycosylation and minimizes side reactions in downstream transformations, making it vital for process reproducibility and product purity. Clients emphasize the controlled release of acetyl groups under monitored conditions, ensuring clean conversion for regulated drug intermediates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Carbohydrate-Based Prodrug ManufactureChemical and pharmaceutical ingredient firms source this compound when developing carbohydrate prodrugs requiring acetyl-protected ribose cores for subsequent activation or bioconjugation. The fully protected ribose prevents premature hydrolysis during multi-step synthesis, supports selective deprotection, and delivers reliable performance even at pilot or commercial scale, with consistent batch-to-batch purity and traceability demanded by prodrug innovators. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Chemical Intermediates for Fine ChemicalsManufacturers of high-value fine chemicals and research reagents employ this tetraacetate for building ribose frameworks in chiral catalysts, diagnostic agents, and fluorinated sugar derivatives. Our customers require the defined acetylation profile to avoid side-products, and routinely commission custom documentation for their downstream quality audits, especially when producing lab-scale reference standards or batch-validated biochemicals. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Active Ingredient in Diagnostic Kit ManufacturingProducers of biochemical diagnostic kits utilize the protected ribose form as a precursor for enzyme substrates and chromogenic systems, as it delivers consistently high conversion rates and meets comprehensive safety and biocompatibility standards. Controlled acetyl content and detailed batch QC support traceability from bench to commercial IVD kit lots, facilitating regulatory clearance and ensuring uniformity across global deployments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Beta-D-Ribofuranose 1,2,3,5-Tetraacetate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In our plant, the synthesis of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate has come a long way from early days spent with fragile glassware and unpredictable yields. Over time, improvements in reaction control and purification transformed the process into a reliable, scalable operation. This compound, a fully protected ribose, forms the backbone of much of the nucleoside chemistry currently powering pharmaceutical research. With a focus on transparency and real-world performance, we offer this product as not just a chemical, but a carefully refined piece of laboratory craft.
Beta-D-Ribofuranose 1,2,3,5-Tetraacetate stands apart because of its protective acetate groups on every hydroxyl position, locking the ribose in a stable form. Over the years, our production runs taught us that controlling moisture, temperature swings, and acetate source selection makes a measurable difference in product stability and appearance. Every batch aims for white crystalline material, showing robust purity by HPLC and confirmed by NMR. Typical product specifications fall between 98% and 99.5% purity, with minimal inorganic residue—these numbers aren’t theoretical aspirations but consistent outcomes reflected in actual manufacturing history.
In our direct experience, Beta-D-Ribofuranose 1,2,3,5-Tetraacetate lets chemists start with a protected sugar that resists the random side reactions seen with unprotected ribose. It dissolves cleanly in most organic solvents. Acetyl protection leaves the delicate ribose ring untouched until precise deprotection by trained hands. Chemists seeking to couple ribose onto nucleobases find this compound eliminates many yield-robbing by-products.
A tangible benefit appears in scale-up. We hear the same pain points: unprotected ribose leads to batch inconsistency, waste, and time lost on purification. Using this acetate-protected ribose, the story changes. Batches show reproducibility. Downstream reactions move with fewer headaches. Research-scale users, process developers, and kilo-lab teams report lower rejection rates since adopting this compound as their starting point.
Recognition of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate rests on practical results. Decades of sugar chemistry saw a vast landscape of protecting group options—benzoyl, benzyl, isopropylidene, and even mixed acetates and benzoyl systems. Each is suited for narrow windows of application. Acetate groups deliver ease of removal and environment-friendly downstream processing. Removal events proceed under mild, non-acidic conditions; acetate waste stream disposal requires no special protocols, reducing costs and risk to operators.
Other protecting groups can complicate things. Benzoyl-protected sugars bring higher stability, but drive up both deprotection difficulty and waste-disposal burden. Isopropylidene derivatives tie up only some hydroxyls, inviting mismatched reactions downstream. For DNA, RNA, and antiviral agent synthesis, use of tetraacetate means every free position is truly blocked, letting the glycosylation or coupling proceed with precision.
Our plant’s feedback loop—lab, pilot, manufacturing—keeps pointing to acetate protection for applications where clean selectivity, operator safety, and process economy matter. Bulk customers, especially those with green chemistry directives, push for the lowest energy and environmental footprint possible. Acetate-protected derivatives answer this challenge better than most alternatives we have examined.
Feedback and partnership with chemists in nucleoside R&D, oligonucleotide start-ups, and generic API facilities shaped our understanding of this compound’s utility. Glycosylation steps are faster and produce fewer side-products. Yields climb, and time spent troubleshooting drops. For teams scaling up, even small improvements in yield or process simplicity can influence months of work and hundreds of kilos of material.
Beyond pharmaceutical chemistry, Beta-D-Ribofuranose 1,2,3,5-Tetraacetate sometimes appears in agricultural and specialty chemical projects: rare, but not unknown. Its protected structure enables exploration of derivatization and fine-tuning for rare sugar projects, though nucleoside work remains its anchor point.
Production of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate benefits from lessons learned on dozens of analogous sugar acetates and decades of batch record reviews. Equipment maintenance, solvent conditioning, and batch-to-batch analytics all play a role. We adopted closed-loop solvent recovery to keep cost and environmental impact in check. Close control of acetic anhydride grade, improved batch temperature ramping, and real-time NMR analytics contributed to tight process control. Such investments show up in the solid, snow-white crystals recovered after each filtration cycle.
On the plant floor, veteran operators value a compound that resists hydrolysis and clumping in storage. Our current process delivers a product that stores for months with no loss in critical specs, so nobody wastes time on drum-to-drum sampling or reprocessing. Drum stabilization and transportation resistance rose up as essential points as we moved from kilogram to ton-scale batches.
From contract manufacturers to R&D innovators, customer conversations pull this product forward. API campaigns can tolerate little waste or product uncertainty, so every minor flaw in feedstock quickly multiplies in impact. By connecting the process chain—from starting ribose procurement through acetylation, to final filter and pack-out—problems get trapped early. Stringent in-process controls, experienced purification, and full spectra documentation answer the needs of the most demanding users. Purity, traceability, and batch reproducibility became more valuable than any simple cost-per-kilo advantage alone.
As a manufacturer, seeing the shift to digitally tracked production lots, QR-coded drums, and synchronized analytical records, we recognize the rising demand for information transparency. Increasing focus on regulatory compliance meant more than box-checking; it meant accessible, verifiable analytical documentation that holds up in audits or technology transfers.
Few challenges frustrate lab teams more than hidden inconsistencies between batches. Every failed coupling or incomplete reaction can swallow days of labor and expensive downstream masks. Early formulations in our facility suffered from batch drift—with even small changes in raw material quality creating chain-reaction losses for high-precision syntheses. By locking down vendor qualification and process monitoring, our site cut batch drift events to near zero. Discussions with both internal and external chemists set the gold standard for documentation.
Shipping histories, stability data, and air-exposure logs form part of our final product files. Users building a drug master file or critical project folder benefit from such detail, avoiding the pain of post-release data gaps. This level of tracking grew from our own frustrations supplying regulated industries; every analytical and certification update sprouts from real requests, not generic templates.
Demand for environmentally sound practices highly influenced the evolution in our sugar production lines. Today, Beta-D-Ribofuranose 1,2,3,5-Tetraacetate synthesis at our site runs with solvent recycling exceeding 85% and continuous screening for safer acetylation aids and purification solvents. These steps did not flow naturally from old literature procedures, nor did they result from trend-watching. Operator concern about waste streams and solvent exposure first drove these upgrades; regulatory forces then accelerated adoption.
As users in Europe, the US, and Asia tighten the reins on chemical imports, every process improvement can mean the difference between long-term supply chain partnerships or being left behind. By investing in point-of-use monitoring for aqueous releases and off-gassing, our factory goes further than meeting regional compliance: it paves the way for transparent customer relationships.
On the technical support side, we see repeat questions about solvent compatibility, handling losses, and suitability for different scales of nucleoside synthesis. It’s only through in-plant trials and customer feedback cycles that solutions emerge. Many facilities learn the hard way that low-end ribose tetraacetate, contaminated with mono- and tri-acetate impurities, devastates downstream selectivity, especially as scale rises. Our own quality control system monitors these impurities carefully, rejecting product not up to spec long before any drum leaves the plant.
In past years, we faced hard choices: reducing cost by allowing varied acetate source grades, or sticking with pharmaceutical-grade acetic anhydride. The second path won out. Users demanded reproducibility, and facility reviews confirmed the difference over months of shipments. This knowledge shaped batch records, operator training, and ongoing analytical upgrades.
Handling and long-term storage of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate benefit from robust packaging, stable crystalline habit, and batch-lot documentation. On-site, every drum stores away from humidity, heat, and reactive chemicals. For users, this protection prevents unwanted hydrolysis, meaning nobody sacrifices yield or cleanliness. Regular re-testing extends confidence for long-term campaigns, so customers aren’t left requalifying product or struggling with outdated lots.
Stable compounds enable steady workflows, and steady workflows save both tension and money. By direct inquiry, our support team often finds that even small advice — such as proper closed containers during transfers, or proactive desiccant use — means tangible improvements in both longevity and process success.
It’s one thing to tout a process as robust or a product as high-purity; it’s another to show year-over-year batch analytics with minimal deviation. Technical site visits, third-party audits, and direct cGMP compliance reviews measure the difference. Our quality system connects every bag of raw material, production cycle, and final drum to a digital file, accessible to customer or regulator alike. Material moving into regulated environments travels with complete analytical data, impurity profiles, and comprehensive spectra — not just single-point certificates.
Customers value fast answers to technical questions with answers rooted in manufacturing experience, not generic datasheets. Much of our success in growing Beta-D-Ribofuranose 1,2,3,5-Tetraacetate volumes comes from this “open plant” approach: users talk directly to the managers who oversee each batch, not to a distant sales intermediary. Operator notes, batch logbooks, and exception records all contribute to the partnership that results in truly reliable supply and specification.
Among the biggest concerns in the chemical industry today stands the security of building block supply. Faced with years of production interruptions, shipping delays, import rules, and ever-tighter logistics, buyers of Beta-D-Ribofuranose 1,2,3,5-Tetraacetate—especially those in pharmaceuticals—demand guarantees. We work with multi-year raw material contracts, snapshot vendor audits, and forward-looking inventory practices. Holding safety stocks became the rule, not the exception. Lessons learned during global supply disruptions reinforced this approach.
Routine system stress tests, mock-recall drills, and open traceability allow buyers to forecast not only cost, but business risk. As the sensitivity of customers grows—especially where fast scale-up or technology transfer is at stake—our plant’s role shifts from basic supplier to technical partner. In unstable times, a direct line to manufacturing pays off, especially for those operating under regulatory scrutiny or rapid innovation cycles.
Beta-D-Ribofuranose 1,2,3,5-Tetraacetate now stands as an anchor point in modern carbohydrate chemistry, not because of broad claims or market trends, but because it passed real tests on the laboratory bench, in pilot vessels, and through full-scale reactors. Market demand drove us to refine the process; customer feedback changed our documentation; our own observations forged a continuous path of improvement. We supply this compound not as an anonymous commodity, but as a record of technical evolution.
The process history, analytical depth, and sustained reliability reflect decades of navigation through shifting regulations, evolving user needs, and rapid increases in demand for nucleoside intermediates. Chemists and process engineers working at the sharp edge of synthetic or pharmaceutical science value not only a reagent but a company willing to share in the journey from innovation to routine production. Having stood at every step of the process, from starting materials through to packed drums, our team shares that perspective, answering both immediate project needs and long-term partnership goals.